{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:51:10Z","timestamp":1792003870680,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaccas.2026.108253","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:23:31Z","timestamp":1779103411000},"page":"108253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-0380","authenticated-orcid":false,"given":"Aakash","family":"Bavishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Marella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2026.108253_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pcad.2023.05.004","article-title":"Exercise recommendations for patients with hypertrophic cardiomyopathy","volume":"80","author":"Bryde","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jaccas.2026.108253_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2023.05.059","article-title":"Return-to-play for elite athletes with genetic heart diseases predisposing to sudden cardiac death","volume":"82","author":"Martinez","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2026.108253_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"23","key":"10.1016\/j.jaccas.2026.108253_bib4","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2026.108253_bib5","first-page":"e716","article-title":"Clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities: a scientific statement from the American Heart Association and American College of Cardiology","volume":"151","author":"Kim","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jaccas.2026.108253_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11936-021-00934-1","article-title":"Hypertrophic cardiomyopathy: updates through the lens of sports cardiology","volume":"23","author":"Lander","year":"2021","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jaccas.2026.108253_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa2504654","article-title":"Aficamten or metoprolol monotherapy for obstructive hypertrophic cardiomyopathy","volume":"393","author":"Garcia-Pavia","year":"2025","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jaccas.2026.108253_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017185","article-title":"Serial changes in ventricular strain in symptomatic obstructive hypertrophic cardiomyopathy treated with mavacamten: insights from the VALOR-HCM trial","volume":"17","author":"Desai","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jaccas.2026.108253_bib9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jacc.2022.07.014","article-title":"The athlete\u2019s heart\u2014challenges and controversies: JACC focus seminar 4\/4","volume":"80","author":"La Gerche","year":"2022","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926014129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926014129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:47:08Z","timestamp":1791373628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926014129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":9,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666084926014129"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.108253","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.108253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"108253"}}